Intervention Protocol

You have free access to this content

Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer

  1. Balamurugan A Vellayappan1,*,
  2. Yu Yang Soon1,
  3. Geoffrey Y Ku2,
  4. Cheng Nang Leong1,
  5. Jiade J Lu1,
  6. Jeremy CS Tey1

Editorial Group: Cochrane Upper Gastrointestinal and Pancreatic Diseases Group

Published Online: 31 MAY 2013

DOI: 10.1002/14651858.CD010511

How to Cite

Vellayappan BA, Soon YY, Ku GY, Leong CN, Lu JJ, Tey JCS. Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 5. Art. No.: CD010511. DOI: 10.1002/14651858.CD010511.

Author Information

  1. 1

    National University Cancer Institute, Radiation Oncology, Singapore, Singapore

  2. 2

    Memorial Sloan-Kettering Cancer Center, Gastrointestinal Oncology Service, New York, NY, USA

*Balamurugan A Vellayappan, Radiation Oncology, National University Cancer Institute, 1E Kent Ridge Road, NUHS Tower Block, Level 7, Singapore, 119228, Singapore.

Publication History

  1. Publication Status: New
  2. Published Online: 31 MAY 2013




  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To compare the effectiveness and safety of chemoradiotherapy plus surgery with that of chemoradiotherapy alone in people with nonmetastatic esophageal carcinoma in terms of OS, progression-free survival (PFS), quality–of-life (QoL), treatment-related mortality and morbidity.